Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Statistics

Total Valuation

CANF has a market cap or net worth of $15.72 million. The enterprise value is $9.14 million.

Market Cap	15.72M
Enterprise Value	9.14M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025, before market open.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

CANF has 3.97 billion shares outstanding. The number of shares has increased by 87.11% in one year.

Current Share Class	n/a
Shares Outstanding	3.97B
Shares Change (YoY)	+87.11%
Shares Change (QoQ)	+34.83%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	8.63%
Float	5.12B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.08
Forward PS	n/a
PB Ratio	3.76
P/TBV Ratio	3.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	16.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.02.

Current Ratio	3.60
Quick Ratio	3.05
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -264.12% and return on invested capital (ROIC) is -163.99%.

Return on Equity (ROE)	-264.12%
Return on Assets (ROA)	-81.86%
Return on Invested Capital (ROIC)	-163.99%
Return on Capital Employed (ROCE)	-159.54%
Revenue Per Employee	$112,000
Profits Per Employee	-$1.76M
Employee Count	5
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.94% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-80.94%
50-Day Moving Average	0.58
200-Day Moving Average	1.06
Relative Strength Index (RSI)	22.73
Average Volume (20 Days)	276,940

Short Selling Information

Short Interest	48,282
Short Previous Month	102,457
Short % of Shares Out	0.28%
Short % of Float	n/a
Short Ratio (days to cover)	0.17

Income Statement

In the last 12 months, CANF had revenue of $560,000 and -$8.80 million in losses. Loss per share was -$0.00.

Revenue	560,000
Gross Profit	560,000
Operating Income	-8.93M
Pretax Income	-8.80M
Net Income	-8.80M
EBITDA	-8.91M
EBIT	-8.93M
Loss Per Share	-$0.00

Balance Sheet

The company has $6.46 million in cash and $90,000 in debt, giving a net cash position of $6.37 million or $0.00 per share.

Cash & Cash Equivalents	6.46M
Total Debt	90,000
Net Cash	6.37M
Net Cash Per Share	$0.00
Equity (Book Value)	4.18M
Book Value Per Share	0.00
Working Capital	5.50M

Cash Flow

In the last 12 months, operating cash flow was -$8.35 million and capital expenditures -$2,000, giving a free cash flow of -$8.36 million.

Operating Cash Flow	-8.35M
Capital Expenditures	-2,000
Free Cash Flow	-8.36M
FCF Per Share	-$0.00

Margins

Gross Margin	100.00%
Operating Margin	-1,595.36%
Pretax Margin	-1,571.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CANF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-87.11%
Shareholder Yield	-87.11%
Earnings Yield	-55.96%
FCF Yield	-53.13%

Analyst Forecast

The average price target for CANF is $14.50, which is 3,421.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$14.50
Price Target Difference	3,421.13%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date	Jan 9, 2023
Split Type	Reverse
Split Ratio	1:10

Scores

CANF has an Altman Z-Score of -31.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.24
Piotroski F-Score	3